The relationship between malignant and tumor-associated cells provides a new strategy for targeted diagnosis and therapy

Oncoimmunology. 2013 Nov 1;2(11):e26295. doi: 10.4161/onci.26295. Epub 2013 Oct 9.

Abstract

Here, we discuss the intimate relationship that exists between malignant and tumor-associated cells, providing a new strategy for targeted diagnosis and therapy via the screening of single-chain antibodies and aptamers that interact with target cells.

Keywords: aptamer; immunotherapy; single-chain antibodies; tumor cell; tumor-associated cells.